| Naos Emerging Opportunities Company Limited (NCC) ORDINARY FULLY PAID |
Financials |
$27 |
Q2 FY25 Investor Update and Q&A - Presentation Materials
|
4 Feb 2025 9:27AM |
$0.360 |
$0.370 |
risen by
2.78%
|
|
| Viridis Mining and Minerals Limited (VMM) ORDINARY FULLY PAID |
Materials |
$25 |
Reinstatement to Quotation
|
4 Feb 2025 9:27AM |
$0.395 |
$0.330 |
fallen by
16.46%
|
|
VMM - Price-sensitive ASX Announcement
Full Release
Key Points
- Viridis Mining and Minerals Limited is identified by the ticker symbol VMM.
- The trading suspension will be lifted immediately after a capital raising announcement.
- The announcement marks the reinstatement to quotation on the ASX.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Battery Age Minerals Ltd (BM8) ORDINARY FULLY PAID |
Materials |
$8 |
Successful $1.5 million Capital Raise to Advance El Aguila
|
4 Feb 2025 9:27AM |
$0.097 |
$0.078 |
fallen by
19.59%
|
|
BM8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Successful capital raise of A$1.5 million by Battery Age Minerals Ltd.
- Funds will be utilized for advancing the El Aguila Project.
- Placement involved 18,292,683 new shares issued at A$0.082 each.
- Discounts applied to the share price relative to recent closing and average prices.
- Directors and management subscribed for A$210,000 in shares pending approval.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Viridis Mining and Minerals Limited (VMM) ORDINARY FULLY PAID |
Materials |
$25 |
Proposed issue of securities - VMM
|
4 Feb 2025 9:27AM |
$0.395 |
$0.330 |
fallen by
16.46%
|
|
| Viridis Mining and Minerals Limited (VMM) ORDINARY FULLY PAID |
Materials |
$25 |
Proposed issue of securities - VMM
|
4 Feb 2025 9:27AM |
$0.395 |
$0.330 |
fallen by
16.46%
|
|
| Viridis Mining and Minerals Limited (VMM) ORDINARY FULLY PAID |
Materials |
$25 |
VMM Secures Placement Funding to Progress Key Developments
|
4 Feb 2025 9:27AM |
$0.395 |
$0.330 |
fallen by
16.46%
|
|
VMM - Price-sensitive ASX Announcement
Full Release
Key Points
- Viridis has raised $3.5 million through a placement at $0.33 per share.
- The Colossus Project has seen a 140% increase in Mineral Resource Estimate.
- Colossus Project features the largest and highest-grade accumulation of critical magnetic rare earth oxides.
- Funds will be allocated to the Pre-feasibility Study, environmental approvals, and metallurgical test work.
- Viridis is on track to become a cash flow generator in the rare earth sector.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Shaver Shop Group Limited (SSG) ORDINARY FULLY PAID |
Consumer Discretionary |
$174 |
SSG - H1 FY25 Results Briefing Invitation
|
4 Feb 2025 9:26AM |
$1.325 |
$1.330 |
risen by
0.38%
|
|
| BetaShares Nasdaq 100 Yield Maximiser Fund (managed fund) (QMAX) |
Financials |
$30 |
Monthly Notional Derivatives Exposure Report - Jan 2025
|
4 Feb 2025 9:26AM |
$30.970 |
$31.250 |
risen by
0.90%
|
|
| Lake Resources NL (LKE) ORDINARY FULLY PAID |
Materials |
$68 |
Cleansing Notice
|
4 Feb 2025 9:26AM |
$0.039 |
$0.039 |
fallen by
0%
|
|
| Resolution Minerals Ltd (RML) ORDINARY FULLY PAID |
Materials |
$3 |
Application for quotation of securities - RML
|
4 Feb 2025 9:25AM |
$0.011 |
$0.009 |
fallen by
18.18%
|
|
| Emyria Limited (EMD) ORDINARY FULLY PAID |
Health Care |
$16 |
Emyria Reports Promising 3-Month PTSD Treatment Results
|
4 Feb 2025 9:25AM |
$0.035 |
$0.034 |
fallen by
2.86%
|
|
EMD - Price-sensitive ASX Announcement
Full Release
Key Points
- Interim analysis shows a 29.6 point reduction in PCL-5 scores three months post-treatment.
- Quality of life improved with an average increase of 23.5 points in ReQoL-10 scores.
- Emyria's MDMA-assisted therapy program continues to expand and refine based on real-world data.
- Eight patients with severe PTSD showed significant improvement after treatment.
- The program addresses an urgent need for effective PTSD interventions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sarytogan Graphite Limited (SGA) ORDINARY FULLY PAID |
Materials |
$10 |
Copper Anomalism with Possible Porphyry Features at Baynazar
|
4 Feb 2025 9:24AM |
$0.061 |
$0.060 |
fallen by
1.64%
|
|
SGA - Price-sensitive ASX Announcement
Full Release
Key Points
- Sarytogan Graphite Limited provided an update on copper exploration at the Baynazar project.
- A high-resolution aeromagnetic survey was flown, and over 6,000 soil samples were collected.
- An external review confirmed previous results and delineated three new anomalies at the Aminbay prospect.
- The soil sampling program will be infilled and extended ahead of planned drilling programs.
- Kazakhstan is a low-cost copper mining jurisdiction, making it promising for copper porphyry exploration.
- Results from the Aminbay prospect indicate textbook metal zonation consistent with a possible porphyry intrusion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Gold and Copper Ltd (AGC) ORDINARY FULLY PAID |
Materials |
$40 |
Emerging Copper Search Space
|
4 Feb 2025 9:24AM |
$0.135 |
$0.155 |
risen by
14.81%
|
|
AGC - Price-sensitive ASX Announcement
Full Release
Key Points
- Assay results received for the final hole of a diamond program targeting a large IP geophysics anomaly.
- Broad zone of low-grade copper-zinc mineralisation intercepted with peak copper grades to 0.42%.
- New copper mineralisation area identified 600m west of the Achilles deposit.
- Additional copper targets defined by large magnetic high aureoles coincident with IP chargeability anomalies.
- Helicopter-borne EM survey commenced to test for additional mineralisation.
- Scheduled restart of drilling at Achilles next week.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Infini Resources Limited (I88) ORDINARY FULLY PAID |
Materials |
$27 |
Trading Halt
|
4 Feb 2025 9:24AM |
$0.655 |
$0.600 |
fallen by
8.40%
|
|
I88 - Price-sensitive ASX Announcement
Full Release
Key Points
- Infini Resources Limited requested a trading halt.
- The trading halt is pending an announcement regarding capital raising.
- The halt remains until 6 February 2025 or the announcement is made.
- The company is unaware of any reasons for the halt not being granted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| New World Resources Limited (NWC) ORDINARY FULLY PAID |
Materials |
$54 |
Appointment of In-Country Environment & Community Manager
|
4 Feb 2025 9:24AM |
$0.017 |
$0.019 |
risen by
11.76%
|
|
| Vonex Limited. (VN8) ORDINARY FULLY PAID |
Communication Services |
$14 |
Proposed issue of securities - VN8
|
4 Feb 2025 9:24AM |
$0.040 |
$0.037 |
fallen by
7.50%
|
|
| Argenica Therapeutics Limited (AGN) ORDINARY FULLY PAID |
Health Care |
$94 |
ARG-007 Shows Significant Neuroprotection in Main TBI Study
|
4 Feb 2025 9:23AM |
$0.700 |
$0.730 |
risen by
4.29%
|
|
AGN - Price-sensitive ASX Announcement
Full Release
Key Points
- ARG-007 significantly reduced damage to brain cells caused by moderate traumatic brain injury (TBI).
- Biomarker levels of axonal injury and neuroinflammation following ARG-007 treatment were equivalent to non-injured animals.
- The study confirmed the extensive neuroprotective effect of ARG-007 in multiple preclinical studies.
- ARG-007 treated animals showed improvements in motor function tests and a significant reduction in weight loss.
- The results support the continuation of larger animal studies to validate ARG-007 as a therapeutic target for TBI.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rimfire Pacific Mining Limited (RIM) ORDINARY FULLY PAID |
Materials |
$75 |
Currajong confirmed as a new high-grade scandium opportunity
|
4 Feb 2025 9:22AM |
$0.034 |
$0.032 |
fallen by
5.88%
|
|
RIM - Price-sensitive ASX Announcement
Full Release
Key Points
- Currajong confirmed as a new high-grade scandium opportunity.
- Historic drill intercepts highlight scandium potential.
- Drilling has defined a 1,000m x 300m zone of shallow scandium.
- Infill air core drilling planned for late February 2025.
- The Currajong area has previously focused on nickel, cobalt, and PGE.
- Rimfire aims to build a globally significant scandium resource inventory.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Predictive Discovery Ltd (PDI) ORDINARY FULLY PAID |
Materials |
$823 |
Proposed issue of securities - PDI
|
4 Feb 2025 9:22AM |
$0.265 |
$0.350 |
risen by
32.08%
|
|
| Predictive Discovery Ltd (PDI) ORDINARY FULLY PAID |
Materials |
$823 |
A$69M Strategic Placement to Lundin Family and Zijin Mining
|
4 Feb 2025 9:22AM |
$0.265 |
$0.350 |
risen by
32.08%
|
|
PDI - Price-sensitive ASX Announcement
Full Release
Key Points
- PDI raised approximately A$69.2 million through a strategic placement.
- Lundin Family invested approximately A$45.1 million for a 6.5% shareholding.
- Zijin Mining Group invested approximately A$24.1 million for a 3.5% shareholding.
- Funds will advance the Bankan Gold Project's Definitive Feasibility Study.
- PDI will have a pro-forma cash balance of A$98 million after placement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| VRX Silica Limited (VRX) ORDINARY FULLY PAID |
Materials |
$29 |
Trading Halt
|
4 Feb 2025 9:22AM |
$0.046 |
$0.039 |
fallen by
15.22%
|
|
VRX - Price-sensitive ASX Announcement
Full Release
Key Points
- VRX Silica Limited requested a trading halt on its securities.
- The halt is pending an announcement related to the Arrowsmith North Silica Sand Project.
- Trading will resume on February 6, 2025, unless the announcement is made earlier.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vulcan Energy Resources Limited (VUL) ORDINARY FULLY PAID |
Materials |
$909 |
Start of execution works including mobilisation of V20 rig
|
4 Feb 2025 9:20AM |
$4.170 |
$4.180 |
risen by
0.24%
|
|
VUL - Price-sensitive ASX Announcement
Full Release
Key Points
- Start of execution works for Phase One renewable energy and lithium project.
- Mobilisation of V20 drilling rig to Schleidberg well site in Germany.
- Target production of 24,000 tonnes per annum lithium hydroxide monohydrate.
- V20 rig is equipped with 2500 horsepower and 550 tonnes hook load capacity.
- Increased transport activity will occur during rig mobilization.
- Well execution operations scheduled to commence in Q2 2025.
- Focus on establishing a sustainable, European-based lithium supply chain.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vonex Limited. (VN8) ORDINARY FULLY PAID |
Communication Services |
$14 |
Announcement of Non-Renounceable Issue
|
4 Feb 2025 9:20AM |
$0.040 |
$0.037 |
fallen by
7.50%
|
|
VN8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Non-renounceable one for one entitlement offer to raise approximately $13.9 million
- Funds to be used principally to pay down existing debt
- Offer price of $0.037 per new share, a 7.5% discount to the closing price of Vonex shares on 3 February 2025
- Major shareholder, MaxoTel, has committed up to $13 million
- CEO Ian Porter to depart from Vonex on 27 February 2025
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vitrafy Life Sciences Limited (VFY) ORDINARY FULLY PAID |
Health Care |
$60 |
Vitrafy Half Year FY25 Investor Briefing
|
4 Feb 2025 9:19AM |
$1.630 |
$1.500 |
fallen by
7.98%
|
|
| Aspen Group (APZ) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$522 |
HY25 Results Webinar
|
4 Feb 2025 9:19AM |
$2.530 |
$2.600 |
risen by
2.77%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
